Entering text into the input field will update the search result below

Xilio sheds over fifth in value to extend losses to fourth straight session

Dec. 07, 2021 3:43 PM ETXilio Therapeutics, Inc. (XLO)By: Dulan Lokuwithana, SA News Editor

Red arrow And dollar finance decline graph- Stock image

Baris-Ozer/iStock via Getty Images

  • Recording the fourth intra-day decline in a row, the shares of the recently IPO’ed biotech company Xilio Therapeutics (XLO -22.1%) remain at the lowest level since the company’s public debut about one and a half

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.